SYR-619
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SYR-619, covering 2012-05-21 to 2012-05-21. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes Mellitus [Phase 2]